SECTOR:
Other therapeutics
FUND/VEHICLE:
NFLS Direct Investment
INVESTMENT DATE:
2018
GEOGRAPHY:
North America
STATUS CURRENT/FORMER INVESTMENT:
Existing
WEBSITE:
Stealth BioTherapeutics is developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging.